Atif S M, Salam N, Ahmad N, Hasan I M, Jamal H S, Sudhanshu A, Azevedo V, Owais M
Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh 202002, Uttar Pradesh, India.
Vaccine. 2008 Oct 29;26(46):5874-82. doi: 10.1016/j.vaccine.2008.08.013. Epub 2008 Oct 1.
In an earlier study, we provided strong evidence that liposomes made of sperm membrane lipids (spermatosomes) can deliver entrapped molecules to the cytosol of target cells. Now we have evaluated the immunological behavior of spermatosome-encapsulated soluble antigen ovalbumin (OVA) in BALB/c mice. Spermatosome-mediated antigen delivery can affect both cytosolic and endosomal antigen-processing pathways, simultaneously, leading to the generation of CD4+ T-helper and CD8+ cytotoxic T-cell responses. Isotype studies revealed that immunization with spermatosome-encapsulated OVA elicits mainly IgG2a and IgG1 subclasses of antibodies. A potential vaccine candidate should impart long-lasting protection against infection; to this end, immunization with spermatosome-encapsulated OVA resulted in expression of CD44 and CD62L cell-surface markers on T cells, suggestive of a desirable memory response. We conclude that spermatosome encapsulation is a useful strategy for vaccine production, because it enhances the immunological activity of the encapsulated antigen.
在早期的一项研究中,我们提供了有力证据,表明由精子膜脂质制成的脂质体(精子小体)能够将包裹的分子递送至靶细胞的胞质溶胶中。现在我们评估了精子小体包裹的可溶性抗原卵清蛋白(OVA)在BALB/c小鼠中的免疫行为。精子小体介导的抗原递送可同时影响胞质和内体抗原加工途径,从而导致CD4+辅助性T细胞和CD8+细胞毒性T细胞反应的产生。同型研究表明,用精子小体包裹的OVA免疫主要引发IgG2a和IgG1亚类抗体。一种潜在的候选疫苗应能提供针对感染的持久保护;为此,用精子小体包裹的OVA免疫导致T细胞上CD44和CD62L细胞表面标志物的表达,提示产生了理想的记忆反应。我们得出结论,精子小体包裹是一种用于疫苗生产的有用策略,因为它增强了包裹抗原的免疫活性。